{"_id":"T3iR5TAh6vr3P6bTm","bibbaseid":"lewis-lortholary-spellberg-roilides-kontoyiannis-walsh-howdoesantifungalpharmacologydifferformucormycosisversusaspergillosis-2012","author_short":["Lewis, R. E.","Lortholary, O.","Spellberg, B.","Roilides, E.","Kontoyiannis, D. P.","Walsh, T. J."],"bibdata":{"bibtype":"article","type":"Article","author":[{"propositions":[],"lastnames":["Lewis"],"firstnames":["Russell","E."],"suffixes":[]},{"propositions":[],"lastnames":["Lortholary"],"firstnames":["Olivier"],"suffixes":[]},{"propositions":[],"lastnames":["Spellberg"],"firstnames":["Brad"],"suffixes":[]},{"propositions":[],"lastnames":["Roilides"],"firstnames":["Emmanuel"],"suffixes":[]},{"propositions":[],"lastnames":["Kontoyiannis"],"firstnames":["Dimitrios","P."],"suffixes":[]},{"propositions":[],"lastnames":["Walsh"],"firstnames":["Thomas","J."],"suffixes":[]}],"title":"How does antifungal pharmacology differ for mucormycosis versus aspergillosis?","year":"2012","journal":"Clinical Infectious Diseases","volume":"54","number":"SUPPL. 1","pages":"S67–S72","doi":"10.1093/cid/cir884","url":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855864796&doi=10.1093%2fcid%2fcir884&partnerID=40&md5=973083cf5094912b65c4f2961c4c5823","publication_stage":"Final","source":"Scopus","note":"Cited by: 52; All Open Access, Bronze Open Access, Green Open Access","bibtex":"@ARTICLE{Lewis2012S67,\n\tauthor = {Lewis, Russell E. and Lortholary, Olivier and Spellberg, Brad and Roilides, Emmanuel and Kontoyiannis, Dimitrios P. and Walsh, Thomas J.},\n\ttitle = {How does antifungal pharmacology differ for mucormycosis versus aspergillosis?},\n\tyear = {2012},\n\tjournal = {Clinical Infectious Diseases},\n\tvolume = {54},\n\tnumber = {SUPPL. 1},\n\tpages = {S67–S72},\n\tdoi = {10.1093/cid/cir884},\n\turl = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855864796&doi=10.1093%2fcid%2fcir884&partnerID=40&md5=973083cf5094912b65c4f2961c4c5823},\n\ttype = {Article},\n\tpublication_stage = {Final},\n\tsource = {Scopus},\n\tnote = {Cited by: 52; All Open Access, Bronze Open Access, Green Open Access}\n}\n\n","author_short":["Lewis, R. E.","Lortholary, O.","Spellberg, B.","Roilides, E.","Kontoyiannis, D. P.","Walsh, T. J."],"key":"Lewis2012S67","id":"Lewis2012S67","bibbaseid":"lewis-lortholary-spellberg-roilides-kontoyiannis-walsh-howdoesantifungalpharmacologydifferformucormycosisversusaspergillosis-2012","role":"author","urls":{"Paper":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855864796&doi=10.1093%2fcid%2fcir884&partnerID=40&md5=973083cf5094912b65c4f2961c4c5823"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/z9HzMuFfTZBTCahC4/scopus.bib","dataSources":["jKN7prtxaY9N8vqst","qLqjc4bwMYLmk2F3c","8E62bsJiEchQrmW6z","NcXuTqLcAyFRTYR5S","Q7T46e3zk4SYE595H"],"keywords":[],"search_terms":["antifungal","pharmacology","differ","mucormycosis","versus","aspergillosis","lewis","lortholary","spellberg","roilides","kontoyiannis","walsh"],"title":"How does antifungal pharmacology differ for mucormycosis versus aspergillosis?","year":2012}